Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization
about
Inhibition of differentiation and function of osteoclasts by dimethyl sulfoxide (DMSO).Meteorin-Like Shows Unique Expression Pattern in Bone and Its Overexpression Inhibits Osteoblast Differentiation.Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.Novel target genes of RUNX2 transcription factor and 1,25-dihydroxyvitamin D3.A p38 Mitogen-Activated Protein Kinase-Regulated Myocyte Enhancer Factor 2-β-Catenin Interaction Enhances Canonical Wnt Signaling.The effect of dimethyl sulfoxide on hepatic differentiation of mesenchymal stem cells.DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells.Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockersInterleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts.MEF2C Interacts With c-FOS in PTH-Stimulated Mmp13 Gene Expression in Osteoblastic Cells.A safety study on single intravenous dose of tetrachloro-diphenyl glycoluril [iodogen] dissolved in dimethyl sulphoxide (DMSO).
P2860
Q30278939-A42B80DD-DC2B-4564-9DC7-855C6A3EE2DDQ36157692-7BE8764B-C162-4652-ACF0-9FA3D666C813Q36727361-3C16944F-AA74-4241-8476-D4D5A01CA716Q36832578-823C870C-971A-43C1-8F97-B6252B6AC3C4Q38307609-6FED7B93-64ED-4311-BCD0-571886E4229FQ38820712-CAF1AB84-139C-4337-B189-64AF170256A8Q38979696-A0F18400-224D-434F-B74A-02E69A74D0CEQ39363935-5813C949-A730-4A33-B1D2-774A8DCFFB76Q39463779-3E6B2391-1338-42CA-AD09-84C0CC8E3120Q44849436-8EF49F2F-1B41-4C1B-8DAB-AB0FC2AB4BDEQ47707535-1E40DEDE-4CB1-43EB-AEA9-5CC52D2FD440Q51282734-34BF9D4B-E86E-4795-A9EF-EAB925F0EBA8
P2860
Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization
description
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2011
@ast
im August 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/08/26)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/08/26)
@nl
наукова стаття, опублікована в серпні 2011
@uk
name
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@ast
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@en
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@nl
type
label
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@ast
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@en
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@nl
prefLabel
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@ast
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@en
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@nl
P2093
P2860
P3181
P356
P1476
Myocyte enhancer factor 2c, an ...... (DMSO)-enhanced mineralization
@en
P2093
Alexandre S. Stephens
Carl Hobbs
Desa Bacic-Welsh
Maria Ann Woodruff
Nigel A. Morrison
Sebastien R. Stephens
P2860
P304
30071–30086
P3181
P356
10.1074/JBC.M111.253518
P407
P577
2011-08-26T00:00:00Z